The effect of a ketogenic diet (KD) - a very low carbohydrate and high-fat diet - without caloric restrictions on endurance capacity in healthy adults
The effect of a ketogenic diet (KD) - a very low carbohydrate and high-fat diet - without caloric restrictions on endurance capacity in healthy adults
批准号:
274452328
负责人:
Professor Dr. Hartmut Bertz
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2015
资助国家:
德国
项目状态:
已结题
起止时间:
2014-12-31 至 2017-12-31
中文摘要
生酮饮食(KD)是一种非常低碳水化合物,高脂肪和充足蛋白质的饮食,不限制卡路里,引起一种称为酮症的代谢状态,即血液中酮体水平升高的状态。有一种传统饮食基本上不含碳水化合物,那就是因纽特人的饮食,他们世世代代的饮食主要由哺乳动物、鱼类和鸟类组成,几乎没有蔬菜。KD在20世纪20年代首次被引入我们的社会,用于治疗癫痫,近几十年来作为减肥饮食非常流行。KD通过摄入很少的碳水化合物最直接地抑制胰岛素分泌。胰岛素抑制饮食在针对肿瘤能量代谢的实验动物模型中被证明是有效的。虽然目前推荐癌症患者服用KD的科学证据太少(更大的试验正在进行中),但越来越多的癌症患者在临床试验之外服用KD,而且往往没有医疗监督,这是对频繁的新闻报道和健康书籍关于KD的积极潜力的回应。在抗癌治疗期间和之后经常进行体育锻炼对健康有许多好处,从改善生活质量和癌症相关的疲劳,到减少癌症复发率和几种癌症的死亡率。因此,任何可能影响身体表现和患者坚持锻炼的能力的饮食都值得高度关注。此外,已有证据表明,KDs可能会消耗肌肉和肝糖原储备,并引发虚弱和疲劳的症状性副作用。在迄今为止的文献中,关注减肥研究(热量限制)之外的KD影响的数据有限,并且涉及足够长的干预时间来克服长期低碳水化合物摄入的代谢适应阶段(1-2周)对身体表现的影响。因此,本研究的主要目的是首先评估在没有热量限制的情况下使用KD是否会导致健康成人身体机能(耐力和肌肉力量)的丧失。这项在50名健康成人中进行的前后对比试验的实验干预包括持续6周的KD,之前的准备阶段包括在为期3周的常规课程中如何遵循KD的详细指导。主要结果测量将是在分级自行车运动中测量的最大耗氧率。最大摄氧量反映了一个人的有氧体能,是耐力的关键决定因素。关键的次要指标是力量、身体成分和代谢参数。
英文摘要
The ketogenic diet (KD) is a very low carbohydrate, high-fat and adequate-protein diet that without limiting calories, induces a metabolic condition called ketosis, a state of elevated levels of ketone bodies in the blood. There is one traditional diet known to have been essentially free of carbohydrates, namely that of the Inuits, their diet consisted over generations mainly of mammals, fish and birds and nearly no vegetables. A KD was first introduced in our society to treat epilepsy in the 1920s and has become quite popular in recent decades as a weight-loss diet. A KD inhibits insulin secretion most straightforwardly via the ingestion of very few carbohydrates. An insulin-inhibition diet was proven effective in experimental animal models targeting tumour energy metabolism. Although there is too little scientific evidence currently to recommend a KD in cancer patients (larger trials are ongoing), an increasing number of cancer patients put themselves on a KD outside of clinical trials and often without medical supervision in response to frequent press reports and health books about the positive potential of KDs. Regular physical exercise during and after anti-cancer therapy has been associated with many health benefits, ranging from improvements in quality of life and cancer-related fatigue, to the reduction in cancer recurrences and mortality among several cancers. Therefore, any diet that may compromise physical performance and the patient s capacity to adhere to an exercise regime would be of great concern. Furthermore, there is already evidence of the potential for KDs to deplete muscle and liver glycogen stores and to trigger symptomatic side-effects of weakness and fatigue. In the literature to date, there is limited data focusing on the effect of a KD outside weight-loss studies (caloric restriction) and involving a long enough intervention duration to overcome the metabolic adaption phase to chronically low-carbohydrate intake (1-2 week) on physical performance. Therefore, the major objective of the proposed study is to firstly assess whether the application of a KD without caloric restriction leads to a loss of physical performance (endurance capacity and muscle strength) in healthy adults. The experimental intervention of this before-and-after comparison trial in 50 healthy adults consists of a KD lasting 6 weeks with a previous preparation period consisting of detailed instructions during regular classes over a 3-week period on how to follow a KD. The primary outcome measure will be the maximum rate of oxygen consumption to exhaustion as measured during graded bicycle exercise. VO2max reflects an individual s aerobic physical fitness and is a key determinant of endurance capacity. Key secondary outcome measures are strength, body composition and metabolic parameters.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1186/s12986-016-0136-4
发表时间:
2016
期刊:
Nutrition & metabolism
影响因子:
4.5
作者:
[Urbain P, Bertz H]
通讯作者:
Bertz H
国内基金
海外基金
α-酮戊二酸调控ACMSD介导犬尿氨酸通路代谢重编程在年龄相关性听力损失中的作用及机制研究
-
批准号:82371150
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:侯书乐
-
依托单位: